'Resistant cells' diaporamas de présentation

How do antibiotics play with multidrug transporters in eucaryotic cells ?

519 views • 51 slides

CEO collects high scientific and technical competences. Associated with this Centre are:

527 views • 42 slides

SIR and the Management of Cancer Trial Data

SIR and the Management of Cancer Trial Data. Kate Motohashi Gray Cancer Institute, Northwood, UK. Introduction. BCON Trial Coordinator/ Data Manager since May 2001 Biology background with no experience of databases!. Topics of Discussion. Background to the trial The database

473 views • 31 slides

ECS129 Information and Fluctuations of Information

ECS129 Information and Fluctuations of Information. Patrice Koehl E-mail: koehl@cs.ucdavis.edu. The Cell. 1. Quantum of life: from 1 cell (bacteria), to 10 13 in a human (trivia: there are approx. 10 14 bacteria in our guts!

293 views • 29 slides

Nematoda: Roundworms

Nematoda: Roundworms . First phylum to have the Complete digestive tract: mouth and anus Pseudocoelomate: fluid filled between endoderm and mesoderm Hydrostatic skeleton under pressure which means only one shape is possible (tapered hotdog). Phylum Nematoda.

436 views • 11 slides

Antibiotics and their Risks

Antibiotics and their Risks. Sir Alexander Fleming. Discovered that certain fungi ( penicillium ) inhibited growth of staphlococcus bacteria Used knowledge to formulate first antibiotic penicillin to be used medically. Taking Antibiotics.

201 views • 9 slides

SHP-1 reverses trastuzumab resistance and migration in HER2-positive breast cancer cells through the stat3/p-stat3 pathw

Decreased expression of Src homology region 2 domain containing protein tyrosine phosphatase 1 (SHP-1) was found in human breast cancer cell lines and primary breast cancers. As a candidate tumor suppressor gene, the role of SHP-1 in HER-2-positive breast cancer remains to be elucidated. The aim of the present study was to investigate the effects of upregulated SHP-1 expression in reversing trastuzumab resistance and migration by HER-2-positive breast cancer cells, potentially providing a new target to trastuzumab resistance in anti-HER2 therapy.

73 views • 7 slides

INTRODUCTION

PROTEASOME INHIBITION AND NOT NF- ? B INHIBITION INDUCES APOPTOSIS TO RESISTANT CELLS IN GLUCOCORTICOID-INDUCED APOPTOSIS. George I Lambrou 1 , Apostolos Zaravinos 2 , Maria Adamaki 1 , Dimitrios Spandidos 2 and Spiros Vlahopoulos 1.

160 views • 1 slides